title: How can we bolster the antifungal drug discovery pipeline?
authors.affiliation: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 832 32 Bratislava, Slovakia.
authors.forename: Josef
authors.initials: J
authors.lastname: Jampilek
mesh_terms: D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D055808:Drug Discovery; D025141:Drug Resistance, Fungal / Q000187:drug effects; D054714:Echinocandins / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006027:Glycosides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D053758:Nanoparticles / Q000737:chemistry; D014315:Triterpenes / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: C000592174:ASP9726; D000935:Antifungal Agents; D054714:Echinocandins; D006027:Glycosides; D014315:Triterpenes; C569338:ibrexafungerp
keywords: antifungals; combination; drug design and development; fungicides; mycoses; nanoparticles; resistance